Matinas BioPharma Holdings, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.99 | -100% | -9.07 | -100% |
| P/S |
|
43.41 | 4.07 | 966.49% |
|
|
| P/BV |
|
2.47 | 9.41 | -73.74% |
|
|
| P/FCF |
|
0 | 46.88 | -100% |
|
|
| Ev/Ebitda |
|
-2.03 | 17.44 | -111.63% |
|
|
| Ev/S |
|
42.24 | 4.38 | 864.44% |
|
|
| Ev/FCF |
|
-2.99 | 55.55 | -105.38% |
|
|
| E/P |
|
0 | 0.2163 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-2082.57 | 20.21 | -10405.89% | -23852.47 | -91.27% |
| ROE |
|
-119.2 | -80.94 | 47.27% |
|
|
| ROA |
|
-34.98 | 6.66 | -624.99% |
|
|
| ROIC |
|
0 | 15.68 | -100% |
|
|
| ROS |
|
-2093.25 | 10.5 | -20034.61% |
|
|
| ROCE |
|
-123.49 | 19.22 | -742.4% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1558 | 2.86 | -105.44% | -0.1574 | -1.05% |
| Nеt Debt/Ebitda |
|
0.0561 | 3.72 | -98.49% |
|
|
| Debt/Ratio |
|
0.0542 | 0.2638 | -79.44% |
|
|
| Debt/Equity |
|
1.69 | 4.81 | -64.81% |
|
|
| Debt/Net Income |
|
-0.155 | 6.51 | -102.38% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.24 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.9365 | -100% |
|
|
| DSI |
|
0 | 0.7161 | -100% |
|
|
| Average dividend growth |
|
0 | -0.182 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.26 | -100% |
|
|
| Average percentage for payments |
|
0 | 77.6 | -100% |
|
|
| Difference from average difference in sector |
|
-1.24 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
10/10
|
1117.78 | 446.18 | 150.52% |
| Growth impulse Ebitda 5 years |
|
14.7 | 615.43 | -97.61% |
| Growth impulse Net Income 5 years |
|
47.06 | 553.09 | -91.49% |
| Growth impulse FCF 5 years |
|
6.87 | 330.41 | -97.92% |
| Growth impulse EPS 5 years |
|
-1.59 | 549.99 | -100.29% |
IP Score
3.46/10
